25 XP   0   0   10

Shijiazhuang Yiling Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Yiling together

PenkeI guess you are interested in Shijiazhuang Yiling Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shijiazhuang Yiling Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shijiazhuang Yiling Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shijiazhuang Yiling Pharmaceutical Co Ltd.

Quick analysis of Yiling (30 sec.)










What can you expect buying and holding a share of Yiling? (30 sec.)

How much money do you get?

How much money do you get?
¥0.04
When do you have the money?
1 year
How often do you get paid?
92.5%

What is your share worth?

Current worth
¥7.09
Expected worth in 1 year
¥8.21
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥1.37
Return On Investment
6.8%

For what price can you sell your share?

Current Price per Share
¥20.19
Expected price per share
¥17.80 - ¥22.22
How sure are you?
50%

1. Valuation of Yiling (5 min.)




Live pricePrice per Share (EOD)

¥20.19

Intrinsic Value Per Share

¥3.29 - ¥3.73

Total Value Per Share

¥10.38 - ¥10.82

2. Growth of Yiling (5 min.)




Is Yiling growing?

Current yearPrevious yearGrowGrow %
How rich?$1.6b$1.3b$289.7m18.0%

How much money is Yiling making?

Current yearPrevious yearGrowGrow %
Making money$93.6m$53m$40.5m43.3%
Net Profit Margin18.5%14.7%--

How much money comes from the company's main activities?

3. Financial Health of Yiling (5 min.)




What can you expect buying and holding a share of Yiling? (5 min.)

Welcome investor! Yiling's management wants to use your money to grow the business. In return you get a share of Yiling.

What can you expect buying and holding a share of Yiling?

First you should know what it really means to hold a share of Yiling. And how you can make/lose money.

Speculation

The Price per Share of Yiling is ¥20.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Yiling.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Yiling, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥7.09. Based on the TTM, the Book Value Change Per Share is ¥0.28 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Yiling.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.030.1%0.030.2%0.020.1%0.020.1%
Usd Book Value Change Per Share0.010.1%0.040.2%0.020.1%0.020.1%0.020.1%
Usd Dividend Per Share0.030.2%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.040.2%0.050.2%0.030.1%0.030.1%0.020.1%
Usd Price Per Share3.25-3.74-3.43-3.06-2.97-
Price to Earnings Ratio64.19-37.98-34.95-49.34-77.63-
Price-to-Total Gains Ratio72.87-15.79-250.14-30.24-176.74-
Price to Book Ratio3.31-3.89-4.33-4.58-5.70-
Price-to-Total Gains Ratio72.87-15.79-250.14-30.24-176.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.794296
Number of shares357
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.040.02
Usd Total Gains Per Share0.050.03
Gains per Quarter (357 shares)16.949.74
Gains per Year (357 shares)67.7538.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1135558142529
225110126275168
3381651944176107
45122026255101146
56327533068126185
67633139882152224
78938646696177263
8101441534109202302
9114496602123228341
10127551670137253380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%49.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%34.06.00.085.0%43.06.00.087.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.03.092.5%45.00.04.091.8%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%36.04.00.090.0%45.04.00.091.8%

Fundamentals of Yiling

About Shijiazhuang Yiling Pharmaceutical Co Ltd

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Fundamental data was last updated by Penke on 2024-03-24 03:51:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Shijiazhuang Yiling Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Yiling earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Yiling to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.6% means that ¥0.09 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 8.6%. The company is making a profit. +1
  • The TTM is 18.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ8.6%TTM18.5%-9.9%
TTM18.5%YOY14.7%+3.7%
TTM18.5%5Y13.8%+4.6%
5Y13.8%10Y13.3%+0.5%
1.1.2. Return on Assets

Shows how efficient Yiling is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Yiling to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.9% Return on Assets means that Yiling generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 3.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.9%TTM3.9%-3.0%
TTM3.9%YOY2.7%+1.2%
TTM3.9%5Y2.7%+1.2%
5Y2.7%10Y2.3%+0.4%
1.1.3. Return on Equity

Shows how efficient Yiling is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Yiling to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.3% Return on Equity means Yiling generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 1.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 5.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM5.8%-4.5%
TTM5.8%YOY4.0%+1.8%
TTM5.8%5Y3.7%+2.1%
5Y3.7%10Y3.0%+0.8%

1.2. Operating Efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Yiling is operating .

  • Measures how much profit Yiling makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Yiling to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 6.1% means the company generated ¥0.06  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 6.1%. The company is operating less efficient.
  • The TTM is 5.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.1%TTM5.4%+0.7%
TTM5.4%YOY17.5%-12.1%
TTM5.4%5Y12.8%-7.5%
5Y12.8%10Y7.1%+5.8%
1.2.2. Operating Ratio

Measures how efficient Yiling is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.31 means that the operating costs are ¥1.31 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 1.311. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.156. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.311TTM1.156+0.155
TTM1.156YOY1.191-0.035
TTM1.1565Y1.200-0.044
5Y1.20010Y0.798+0.402

1.3. Liquidity of Shijiazhuang Yiling Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Yiling is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.55 means the company has ¥1.55 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 1.554. The company is able to pay all its short-term debts. +1
  • The TTM is 1.473. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.554TTM1.473+0.081
TTM1.473YOY1.735-0.262
TTM1.4735Y3.288-1.814
5Y3.28810Y1.981+1.307
1.3.2. Quick Ratio

Measures if Yiling is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Yiling to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.66 means the company can pay off ¥0.66 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 0.658. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.556. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.658TTM0.556+0.102
TTM0.556YOY0.751-0.195
TTM0.5565Y1.395-0.839
5Y1.39510Y1.553-0.158

1.4. Solvency of Shijiazhuang Yiling Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Yiling assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Yiling to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.32 means that Yiling assets are financed with 32.0% credit (debt) and the remaining percentage (100% - 32.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 0.320. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.336. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.320TTM0.336-0.015
TTM0.336YOY0.317+0.018
TTM0.3365Y0.245+0.090
5Y0.24510Y0.184+0.061
1.4.2. Debt to Equity Ratio

Measures if Yiling is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Yiling to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 47.1% means that company has ¥0.47 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The MRQ is 0.471. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.505. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.471TTM0.505-0.034
TTM0.505YOY0.466+0.040
TTM0.5055Y0.346+0.159
5Y0.34610Y0.244+0.102

2. Market Valuation of Shijiazhuang Yiling Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Yiling generates.

  • Above 15 is considered overpriced but always compare Yiling to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 64.19 means the investor is paying ¥64.19 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The EOD is 55.239. Based on the earnings, the company is expensive. -2
  • The MRQ is 64.185. Based on the earnings, the company is expensive. -2
  • The TTM is 37.980. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD55.239MRQ64.185-8.947
MRQ64.185TTM37.980+26.205
TTM37.980YOY34.946+3.035
TTM37.9805Y49.337-11.356
5Y49.33710Y77.628-28.291
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The EOD is -13.558. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.754. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 17.961. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-13.558MRQ-15.754+2.196
MRQ-15.754TTM17.961-33.715
TTM17.961YOY45.901-27.940
TTM17.9615Y6.451+11.511
5Y6.45110Y-22.260+28.711
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Yiling is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Shijiazhuang Yiling Pharmaceutical Co Ltd:

  • The EOD is 2.847. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.308. Based on the equity, the company is fair priced.
  • The TTM is 3.891. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.847MRQ3.308-0.461
MRQ3.308TTM3.891-0.583
TTM3.891YOY4.330-0.439
TTM3.8915Y4.581-0.689
5Y4.58110Y5.702-1.121
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shijiazhuang Yiling Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0900.279-68%0.154-42%0.128-29%0.114-21%
Book Value Per Share--7.0926.974+2%5.721+24%5.364+32%4.356+63%
Current Ratio--1.5541.473+5%1.735-10%3.288-53%1.981-22%
Debt To Asset Ratio--0.3200.336-4%0.317+1%0.245+31%0.184+74%
Debt To Equity Ratio--0.4710.505-7%0.466+1%0.346+36%0.244+93%
Dividend Per Share--0.2320.064+261%0.042+447%0.069+235%0.049+369%
Eps--0.0910.204-55%0.230-60%0.172-47%0.123-26%
Free Cash Flow Per Share---0.3720.323-215%0.164-327%0.081-562%0.031-1285%
Free Cash Flow To Equity Per Share---0.4800.357-235%0.139-447%0.066-826%0.041-1259%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--3.730--------
Intrinsic Value_10Y_min--3.291--------
Intrinsic Value_1Y_max--0.512--------
Intrinsic Value_1Y_min--0.503--------
Intrinsic Value_3Y_max--1.433--------
Intrinsic Value_3Y_min--1.371--------
Intrinsic Value_5Y_max--2.227--------
Intrinsic Value_5Y_min--2.077--------
Market Cap33731635223.040-16%39194856975.36045201059482.880-13%41396017421.440-5%41885088253.052-6%38355941122.565+2%
Net Profit Margin--0.0860.185-54%0.147-42%0.138-38%0.133-36%
Operating Margin--0.0610.054+13%0.175-65%0.128-53%0.071-14%
Operating Ratio--1.3111.156+13%1.191+10%1.200+9%0.798+64%
Pb Ratio2.847-16%3.3083.891-15%4.330-24%4.581-28%5.702-42%
Pe Ratio55.239-16%64.18537.980+69%34.946+84%49.337+30%77.628-17%
Price Per Share20.190-16%23.46027.055-13%24.778-5%22.106+6%21.476+9%
Price To Free Cash Flow Ratio-13.558+14%-15.75417.961-188%45.901-134%6.451-344%-22.260+41%
Price To Total Gains Ratio62.714-16%72.87115.789+362%250.144-71%30.236+141%176.741-59%
Quick Ratio--0.6580.556+18%0.751-12%1.395-53%1.553-58%
Return On Assets--0.0090.039-77%0.027-68%0.027-68%0.023-62%
Return On Equity--0.0130.058-78%0.040-68%0.037-66%0.030-57%
Total Gains Per Share--0.3220.343-6%0.197+64%0.197+63%0.163+97%
Usd Book Value--1639769413.9991612623919.506+2%1322840745.463+24%1284655288.036+28%1029399594.660+59%
Usd Book Value Change Per Share--0.0120.039-68%0.021-42%0.018-29%0.016-21%
Usd Book Value Per Share--0.9810.965+2%0.792+24%0.742+32%0.603+63%
Usd Dividend Per Share--0.0320.009+261%0.006+447%0.010+235%0.007+369%
Usd Eps--0.0130.028-55%0.032-60%0.024-47%0.017-26%
Usd Free Cash Flow---86082476.98474791135.113-215%37869579.151-327%20269106.612-525%6819121.372-1362%
Usd Free Cash Flow Per Share---0.0520.045-215%0.023-327%0.011-562%0.004-1285%
Usd Free Cash Flow To Equity Per Share---0.0660.049-235%0.019-447%0.009-826%0.006-1259%
Usd Market Cap4668458314.869-16%5424568205.3906255826632.431-13%5729208811.127-5%5796896214.222-6%5308462251.363+2%
Usd Price Per Share2.794-16%3.2473.744-13%3.429-5%3.059+6%2.972+9%
Usd Profit--21128613.83193633286.283-77%53094201.684-60%50702810.767-58%33831375.500-38%
Usd Revenue--246921760.562455393589.523-46%344306362.844-28%323997774.698-24%226051906.595+9%
Usd Total Gains Per Share--0.0450.047-6%0.027+64%0.027+63%0.023+97%
 EOD+3 -5MRQTTM+14 -21YOY+10 -255Y+11 -2410Y+13 -22

3.2. Fundamental Score

Let's check the fundamental score of Shijiazhuang Yiling Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1555.239
Price to Book Ratio (EOD)Between0-12.847
Net Profit Margin (MRQ)Greater than00.086
Operating Margin (MRQ)Greater than00.061
Quick Ratio (MRQ)Greater than10.658
Current Ratio (MRQ)Greater than11.554
Debt to Asset Ratio (MRQ)Less than10.320
Debt to Equity Ratio (MRQ)Less than10.471
Return on Equity (MRQ)Greater than0.150.013
Return on Assets (MRQ)Greater than0.050.009
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Shijiazhuang Yiling Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.861
Ma 20Greater thanMa 5021.157
Ma 50Greater thanMa 10021.282
Ma 100Greater thanMa 20022.427
OpenGreater thanClose20.110
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets17,435,004
Total Liabilities5,586,959
Total Stockholder Equity11,856,443
 As reported
Total Liabilities 5,586,959
Total Stockholder Equity+ 11,856,443
Total Assets = 17,435,004

Assets

Total Assets17,435,004
Total Current Assets6,824,834
Long-term Assets10,610,170
Total Current Assets
Cash And Cash Equivalents 1,072,619
Short-term Investments 236,011
Net Receivables 2,653,091
Inventory 2,426,613
Other Current Assets 436,500
Total Current Assets  (as reported)6,824,834
Total Current Assets  (calculated)6,824,834
+/- 0
Long-term Assets
Property Plant Equipment 6,990,863
Goodwill 114,237
Intangible Assets 908,792
Other Assets 2,742,712
Long-term Assets  (as reported)10,610,170
Long-term Assets  (calculated)10,756,604
+/- 146,435

Liabilities & Shareholders' Equity

Total Current Liabilities4,391,962
Long-term Liabilities1,194,997
Total Stockholder Equity11,856,443
Total Current Liabilities
Short Long Term Debt 900,503
Accounts payable 2,306,402
Other Current Liabilities 944,891
Total Current Liabilities  (as reported)4,391,962
Total Current Liabilities  (calculated)4,151,796
+/- 240,166
Long-term Liabilities
Long term Debt 700,401
Capital Lease Obligations Min Short Term Debt12,662
Other Liabilities 481,934
Deferred Long Term Liability 159,975
Long-term Liabilities  (as reported)1,194,997
Long-term Liabilities  (calculated)1,354,973
+/- 159,975
Total Stockholder Equity
Common Stock1,670,705
Retained Earnings 7,849,281
Total Stockholder Equity (as reported)11,856,443
Total Stockholder Equity (calculated)9,519,986
+/- 2,336,457
Other
Capital Stock1,670,705
Common Stock Shares Outstanding 1,670,705
Net Debt 528,285
Net Invested Capital 13,457,347
Net Tangible Assets 10,990,782
Net Working Capital 2,432,872
Property Plant and Equipment Gross 6,990,863



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302010-12-312009-12-312008-12-31
> Total Assets 
831,912
1,509,441
1,771,111
1,892,882
4,161,857
4,225,417
4,273,219
4,240,702
4,320,373
4,165,722
4,324,282
4,569,957
4,709,599
4,658,034
4,821,362
4,987,896
5,020,844
5,087,911
5,173,087
5,496,074
5,789,855
5,706,959
5,847,343
6,048,559
6,229,649
6,250,452
7,954,985
7,973,738
7,751,185
7,887,369
8,191,150
8,311,953
8,450,992
8,557,219
8,818,641
8,847,859
8,910,781
9,069,397
9,826,189
10,127,061
10,714,840
11,492,338
13,510,002
14,231,497
12,984,144
12,904,842
13,852,193
14,384,014
14,924,895
16,336,113
18,246,701
18,153,599
17,435,004
17,435,00418,153,59918,246,70116,336,11314,924,89514,384,01413,852,19312,904,84212,984,14414,231,49713,510,00211,492,33810,714,84010,127,0619,826,1899,069,3978,910,7818,847,8598,818,6418,557,2198,450,9928,311,9538,191,1507,887,3697,751,1857,973,7387,954,9856,250,4526,229,6496,048,5595,847,3435,706,9595,789,8555,496,0745,173,0875,087,9115,020,8444,987,8964,821,3624,658,0344,709,5994,569,9574,324,2824,165,7224,320,3734,240,7024,273,2194,225,4174,161,8571,892,8821,771,1111,509,441831,912
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,599,117
4,779,251
4,898,266
5,151,603
5,154,274
5,081,144
5,068,197
5,699,143
5,592,802
5,380,847
5,459,430
6,999,136
7,394,993
5,893,640
5,602,135
6,253,151
6,592,888
7,111,780
7,254,187
8,459,997
7,457,074
6,824,834
6,824,8347,457,0748,459,9977,254,1877,111,7806,592,8886,253,1515,602,1355,893,6407,394,9936,999,1365,459,4305,380,8475,592,8025,699,1435,068,1975,081,1445,154,2745,151,6034,898,2664,779,2514,599,1170000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,348,325
996,338
777,261
846,534
547,156
744,733
733,411
1,192,757
1,383,949
1,466,418
1,336,983
1,444,016
2,025,565
1,024,371
995,260
1,292,697
1,721,919
1,760,739
1,904,276
1,035,610
1,755,175
1,072,619
1,072,6191,755,1751,035,6101,904,2761,760,7391,721,9191,292,697995,2601,024,3712,025,5651,444,0161,336,9831,466,4181,383,9491,192,757733,411744,733547,156846,534777,261996,3381,348,3250000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
412,843
0
353,051
706,332
887,920
532,885
292,728
1,084,041
1,082,746
386,375
216,975
185,032
54,617
55,079
55,273
155,950
104,349
254,664
518,383
1,395,722
404,672
236,011
236,011404,6721,395,722518,383254,664104,349155,95055,27355,07954,617185,032216,975386,3751,082,7461,084,041292,728532,885887,920706,332353,0510412,8430000000000000000000000000000000
       Net Receivables 
150,062
378,566
197,023
269,892
442,783
616,716
716,346
564,908
485,501
366,792
360,643
447,049
487,943
471,207
542,136
576,641
612,562
438,394
591,673
885,138
938,506
658,062
885,965
881,913
1,120,926
879,656
1,412,462
1,467,325
1,291,532
1,286,555
1,835,194
1,666,087
1,901,005
1,978,389
1,007,082
1,263,558
1,369,808
2,424,278
1,702,965
1,502,101
1,463,047
1,774,542
3,063,814
2,785,995
2,651,644
2,373,201
2,612,790
2,567,502
2,922,720
1,726,807
1,938,660
2,439,777
2,653,091
2,653,0912,439,7771,938,6601,726,8072,922,7202,567,5022,612,7902,373,2012,651,6442,785,9953,063,8141,774,5421,463,0471,502,1011,702,9652,424,2781,369,8081,263,5581,007,0821,978,3891,901,0051,666,0871,835,1941,286,5551,291,5321,467,3251,412,462879,6561,120,926881,913885,965658,062938,506885,138591,673438,394612,562576,641542,136471,207487,943447,049360,643366,792485,501564,908716,346616,716442,783269,892197,023378,566150,062
       Inventory 
67,827
144,446
210,131
197,079
291,225
326,746
321,340
375,098
462,965
455,660
443,149
506,714
502,543
618,383
591,021
610,819
741,702
833,741
801,999
782,703
908,113
1,037,865
977,276
936,448
922,138
921,733
853,186
1,058,792
1,020,619
1,075,576
990,141
1,005,316
1,058,172
1,175,668
1,251,114
1,186,721
1,235,678
1,221,813
1,350,687
1,289,502
1,504,827
1,580,345
1,667,765
2,002,067
1,618,808
1,672,746
1,673,957
1,956,901
1,682,165
2,021,822
2,822,132
2,512,358
2,426,613
2,426,6132,512,3582,822,1322,021,8221,682,1651,956,9011,673,9571,672,7461,618,8082,002,0671,667,7651,580,3451,504,8271,289,5021,350,6871,221,8131,235,6781,186,7211,251,1141,175,6681,058,1721,005,316990,1411,075,5761,020,6191,058,792853,186921,733922,138936,448977,2761,037,865908,113782,703801,999833,741741,702610,819591,021618,383502,543506,714443,149455,660462,965375,098321,340326,746291,225197,079210,131144,44667,827
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,667,038
3,693,585
3,829,637
4,001,200
4,127,046
4,534,259
5,333,992
6,032,908
6,510,866
6,836,505
7,090,504
7,302,708
7,599,041
7,791,126
7,813,115
9,081,925
9,786,704
10,696,524
10,610,170
10,610,17010,696,5249,786,7049,081,9257,813,1157,791,1267,599,0417,302,7087,090,5046,836,5056,510,8666,032,9085,333,9924,534,2594,127,0464,001,2003,829,6373,693,5853,667,0380000000000000000000000000000000000
       Property Plant Equipment 
370,909
562,094
858,797
628,573
716,389
1,019,033
806,856
1,164,881
994,786
1,424,629
1,184,627
1,552,960
1,379,514
1,839,313
1,562,018
1,712,534
1,795,841
1,965,823
2,082,558
2,215,711
2,384,435
2,733,717
2,440,254
2,769,301
2,749,910
2,734,683
2,997,734
3,016,632
2,994,505
3,006,845
2,966,510
2,935,238
2,872,767
2,862,436
2,821,476
2,858,181
2,876,120
3,060,337
3,068,239
3,107,157
3,341,271
4,312,937
4,761,779
5,193,938
5,455,317
5,757,844
5,728,411
5,959,196
6,054,663
6,221,788
6,353,298
7,008,243
6,990,863
6,990,8637,008,2436,353,2986,221,7886,054,6635,959,1965,728,4115,757,8445,455,3175,193,9384,761,7794,312,9373,341,2713,107,1573,068,2393,060,3372,876,1202,858,1812,821,4762,862,4362,872,7672,935,2382,966,5103,006,8452,994,5053,016,6322,997,7342,734,6832,749,9102,769,3012,440,2542,733,7172,384,4352,215,7112,082,5581,965,8231,795,8411,712,5341,562,0181,839,3131,379,5141,552,9601,184,6271,424,629994,7861,164,881806,8561,019,033716,389628,573858,797562,094370,909
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
520
0
0
0
0
0
0
0
0
0
0
0
0
12,605
13,503
11,919
11,919
11,919
11,919
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
114,237
114,237
114,237114,23700000000000000000011,91911,91911,91911,91913,50312,60500000000000052000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,141
91,367
50,456
50,402
53,165
53,165
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000053,16553,16550,40250,45691,36790,1410000000000000000000000000000000
       Intangible Assets 
12,024
14,328
10,937
256,062
253,586
9,159
262,828
12,168
330,161
21,378
338,403
20,479
343,063
24,480
334,814
333,792
330,869
332,958
344,538
341,603
338,884
358,017
354,738
350,486
346,260
354,111
350,478
361,648
358,276
353,626
349,623
347,626
344,082
352,549
600,624
277,439
674,767
754,391
761,634
792,910
808,011
736,650
716,778
731,076
760,359
897,946
1,006,825
997,752
1,005,876
827,955
828,604
879,940
908,792
908,792879,940828,604827,9551,005,876997,7521,006,825897,946760,359731,076716,778736,650808,011792,910761,634754,391674,767277,439600,624352,549344,082347,626349,623353,626358,276361,648350,478354,111346,260350,486354,738358,017338,884341,603344,538332,958330,869333,792334,81424,480343,06320,479338,40321,378330,16112,168262,8289,159253,586256,06210,93714,32812,024
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
109,093
98,288
147,259
91,071
193,917
518,096
4,382,376
829,359
814,597
768,865
728,029
502,764
667,860
617,678
541,488
369,307
469,644
444,217
474,707
474,707444,217469,644369,307541,488617,678667,860502,764728,029768,865814,597829,3594,382,376518,096193,91791,071147,25998,288109,0930000000000000000000000000000000000
> Total Liabilities 
347,879
718,893
680,077
626,869
618,723
523,776
490,001
439,768
500,734
320,751
409,556
427,451
481,460
399,693
459,925
588,704
532,222
533,810
493,568
773,897
941,378
879,558
836,340
1,022,184
1,078,126
917,827
1,114,663
1,135,173
796,187
775,580
759,021
852,731
878,303
993,559
1,019,884
994,184
987,963
1,116,852
1,435,377
1,699,297
1,990,027
2,568,985
3,911,363
5,537,445
4,031,223
3,832,673
4,296,682
4,764,715
4,939,483
5,405,841
6,114,648
6,456,340
5,586,959
5,586,9596,456,3406,114,6485,405,8414,939,4834,764,7154,296,6823,832,6734,031,2235,537,4453,911,3632,568,9851,990,0271,699,2971,435,3771,116,852987,963994,1841,019,884993,559878,303852,731759,021775,580796,1871,135,1731,114,663917,8271,078,1261,022,184836,340879,558941,378773,897493,568533,810532,222588,704459,925399,693481,460427,451409,556320,751500,734439,768490,001523,776618,723626,869680,077718,893347,879
   > Total Current Liabilities 
288,420
640,751
534,100
419,297
411,252
373,980
330,236
268,147
296,748
130,222
216,770
268,025
322,795
247,026
303,098
429,241
366,181
367,265
331,952
595,998
766,805
707,423
664,223
842,636
897,007
740,612
932,897
953,077
620,700
607,295
593,998
684,165
707,263
764,662
791,688
765,860
761,913
806,432
1,109,274
1,366,169
1,643,543
2,238,879
3,585,254
4,688,444
3,186,151
2,960,445
3,436,486
4,259,452
4,230,483
4,850,132
5,562,442
5,639,380
4,391,962
4,391,9625,639,3805,562,4424,850,1324,230,4834,259,4523,436,4862,960,4453,186,1514,688,4443,585,2542,238,8791,643,5431,366,1691,109,274806,432761,913765,860791,688764,662707,263684,165593,998607,295620,700953,077932,897740,612897,007842,636664,223707,423766,805595,998331,952367,265366,181429,241303,098247,026322,795268,025216,770130,222296,748268,147330,236373,980411,252419,297534,100640,751288,420
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,051
90,065
290,176
270,160
270,177
570,480
500,417
500,417
500,472
400,349
300,229
400,279
500,345
700,416
1,000,572
900,503
900,5031,000,572700,416500,345400,279300,229400,349500,472500,417500,417570,480270,177270,160290,17690,06550,0510000000000000000000000000000000000000
       Accounts payable 
46,400
115,871
86,529
78,118
57,800
72,769
68,855
69,633
113,999
69,809
96,771
124,992
204,297
141,896
184,478
219,754
211,003
247,076
200,029
348,710
502,344
373,246
327,404
424,801
416,894
307,710
451,518
563,020
342,027
353,045
389,436
390,173
362,923
389,040
496,083
494,314
480,669
424,952
729,021
731,909
892,739
1,188,385
1,592,198
1,682,839
1,666,278
1,621,195
1,880,824
2,303,539
2,369,376
2,060,776
2,788,444
2,860,274
2,306,402
2,306,4022,860,2742,788,4442,060,7762,369,3762,303,5391,880,8241,621,1951,666,2781,682,8391,592,1981,188,385892,739731,909729,021424,952480,669494,314496,083389,040362,923390,173389,436353,045342,027563,020451,518307,710416,894424,801327,404373,246502,344348,710200,029247,076211,003219,754184,478141,896204,297124,99296,77169,809113,99969,63368,85572,76957,80078,11886,529115,87146,400
       Other Current Liabilities 
212,020
524,880
287,571
136,179
162,452
100,211
106,381
108,514
102,749
60,413
119,999
143,033
118,498
105,130
118,620
209,487
155,177
120,189
131,924
187,288
154,461
284,177
286,819
367,836
380,113
332,902
381,379
390,057
278,673
254,249
204,562
176,533
326,363
256,780
247,377
137,778
233,220
162,031
169,135
141,527
331,523
445,016
1,200,831
1,662,336
619,066
353,632
1,015,767
1,155,717
1,283,411
53,215
1,611,073
1,390,526
944,891
944,8911,390,5261,611,07353,2151,283,4111,155,7171,015,767353,632619,0661,662,3361,200,831445,016331,523141,527169,135162,031233,220137,778247,377256,780326,363176,533204,562254,249278,673390,057381,379332,902380,113367,836286,819284,177154,461187,288131,924120,189155,177209,487118,620105,130118,498143,033119,99960,413102,749108,514106,381100,211162,452136,179287,571524,880212,020
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
228,196
228,323
226,050
310,420
326,104
333,129
346,484
330,106
326,109
849,001
845,072
872,228
860,195
505,263
709,000
555,709
552,206
816,961
1,194,997
1,194,997816,961552,206555,709709,000505,263860,195872,228845,072849,001326,109330,106346,484333,129326,104310,420226,050228,323228,1960000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,531
5,288
2,538
2,370
14,973
14,039
13,274
12,662
12,66213,27414,03914,9732,3702,5385,28812,531000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
209,882
217,731
216,181
228,749
238,411
255,661
299,536
312,672
319,427
331,975
261,170
227,244
260,558
271,725
239,326
223,967
224,206
226,553
0
0
124,207
159,975
159,975124,20700226,553224,206223,967239,326271,725260,558227,244261,170331,975319,427312,672299,536255,661238,411228,749216,181217,731209,8820000000000000000000000000000000
> Total Stockholder Equity
481,504
787,687
1,091,034
1,266,013
3,543,134
3,701,642
3,783,218
3,800,934
3,819,639
3,844,971
3,914,726
4,142,506
4,228,139
4,258,341
4,361,438
4,399,192
4,488,621
4,554,102
4,679,519
4,722,177
4,842,970
4,815,605
5,000,121
5,017,111
5,143,022
5,321,836
6,830,285
6,836,614
6,952,832
7,110,188
7,431,045
7,458,090
7,572,202
7,561,126
7,796,588
7,843,723
7,913,668
7,944,415
8,383,013
8,420,608
8,719,521
8,919,266
9,594,196
8,689,840
8,949,705
9,069,132
9,553,282
9,617,570
9,984,489
10,932,217
12,135,076
11,703,879
11,856,443
11,856,44311,703,87912,135,07610,932,2179,984,4899,617,5709,553,2829,069,1328,949,7058,689,8409,594,1968,919,2668,719,5218,420,6088,383,0137,944,4157,913,6687,843,7237,796,5887,561,1267,572,2027,458,0907,431,0457,110,1886,952,8326,836,6146,830,2855,321,8365,143,0225,017,1115,000,1214,815,6054,842,9704,722,1774,679,5194,554,1024,488,6214,399,1924,361,4384,258,3414,228,1394,142,5063,914,7263,844,9713,819,6393,800,9343,783,2183,701,6423,543,1341,266,0131,091,034787,687481,504
   Common Stock
79,866
79,866
360,000
360,000
425,000
425,000
425,000
552,500
552,500
552,500
552,500
562,912
563,884
563,884
563,884
563,450
563,390
563,390
563,390
1,126,502
1,127,194
1,127,648
1,127,648
1,127,666
1,127,732
1,128,785
1,203,390
1,204,026
1,204,518
1,204,636
1,205,544
1,206,307
1,206,307
1,206,307
1,206,307
1,206,307
1,206,307
1,203,717
1,203,717
1,203,717
1,203,717
1,203,717
1,203,717
1,670,705
1,670,705
1,670,705
1,670,705
1,670,705
1,670,705
0
0
1,670,705
1,670,705
1,670,7051,670,705001,670,7051,670,7051,670,7051,670,7051,670,7051,670,7051,203,7171,203,7171,203,7171,203,7171,203,7171,203,7171,206,3071,206,3071,206,3071,206,3071,206,3071,206,3071,205,5441,204,6361,204,5181,204,0261,203,3901,128,7851,127,7321,127,6661,127,6481,127,6481,127,1941,126,502563,390563,390563,390563,450563,884563,884563,884562,912552,500552,500552,500552,500425,000425,000425,000360,000360,00079,86679,866
   Retained Earnings 
267,470
564,560
571,905
746,884
867,611
990,870
1,072,470
1,090,157
1,108,834
1,117,912
1,187,808
1,214,330
1,285,619
1,293,064
1,559,894
1,603,624
1,692,857
1,756,992
1,880,589
1,923,428
2,031,431
2,131,144
2,314,766
2,329,394
2,453,625
2,560,381
2,768,518
2,767,909
2,878,019
2,969,479
3,280,143
3,296,915
3,410,659
3,448,071
3,360,090
3,406,718
3,526,873
3,934,795
4,372,770
4,410,359
4,712,242
4,914,861
5,589,549
4,685,616
4,945,166
5,065,356
5,549,671
5,612,717
5,978,469
5,989,178
7,191,693
7,696,617
7,849,281
7,849,2817,696,6177,191,6935,989,1785,978,4695,612,7175,549,6715,065,3564,945,1664,685,6165,589,5494,914,8614,712,2424,410,3594,372,7703,934,7953,526,8733,406,7183,360,0903,448,0713,410,6593,296,9153,280,1432,969,4792,878,0192,767,9092,768,5182,560,3812,453,6252,329,3942,314,7662,131,1442,031,4311,923,4281,880,5891,756,9921,692,8571,603,6241,559,8941,293,0641,285,6191,214,3301,187,8081,117,9121,108,8341,090,1571,072,470990,870867,611746,884571,905564,560267,470
   Capital Surplus 00000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000-67,014-67,014-67,014-67,014-135,027-135,027-135,027-135,027000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,920
-4,552
-3,877
-4,441
-3,934
-3,053
-3,867
-3,243
-3,237
-6,207
-9,081
-8,839
-9,263
2,333,834
-9,710
-9,875
-8,633
-7,466
0
0
53,243
-6,324
-6,32453,24300-7,466-8,633-9,875-9,7102,333,834-9,263-8,839-9,081-6,207-3,237-3,243-3,867-3,053-3,934-4,441-3,877-4,552-4,9200000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue13,161,664
Cost of Revenue-4,867,045
Gross Profit8,294,6208,294,620
 
Operating Income (+$)
Gross Profit8,294,620
Operating Expense-9,849,288
Operating Income3,312,377-1,554,668
 
Operating Expense (+$)
Research Development1,074,035
Selling General Administrative3,413,245
Selling And Marketing Expenses-
Operating Expense9,849,2884,487,280
 
Net Interest Income (+$)
Interest Income14,337
Interest Expense-36,754
Other Finance Cost-5,870
Net Interest Income-28,288
 
Pretax Income (+$)
Operating Income3,312,377
Net Interest Income-28,288
Other Non-Operating Income Expenses-
Income Before Tax (EBT)3,181,6203,312,377
EBIT - interestExpense = -36,754
2,706,164
2,742,919
Interest Expense36,754
Earnings Before Interest and Taxes (EBIT)-3,218,374
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax3,181,620
Tax Provision-482,982
Net Income From Continuing Ops2,698,6382,698,638
Net Income2,706,164
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-28,288
 

Technical Analysis of Yiling
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Yiling. The general trend of Yiling is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Yiling's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shijiazhuang Yiling Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 20.62 < 22.03 < 22.22.

The bearish price targets are: 18.44 > 17.80.

Tweet this
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current macd is -0.26073246.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Yiling price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Yiling. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Yiling price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current adx is 15.53.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Yiling shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current sar is 21.72.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current rsi is 34.86. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Yiling price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current cci is -160.70863651.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current cmo is -45.61946189.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current willr is -86.38497653.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Williams %R ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shijiazhuang Yiling Pharmaceutical Co Ltd.

Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current atr is 0.49251624.

Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current obv is 1,325,365,468.

Shijiazhuang Yiling Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shijiazhuang Yiling Pharmaceutical Co Ltd. The current mfi is 45.15.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartShijiazhuang Yiling Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shijiazhuang Yiling Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Shijiazhuang Yiling Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shijiazhuang Yiling Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.861
Ma 20Greater thanMa 5021.157
Ma 50Greater thanMa 10021.282
Ma 100Greater thanMa 20022.427
OpenGreater thanClose20.110
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Yiling with someone you think should read this too:
  • Are you bullish or bearish on Yiling? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Yiling? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shijiazhuang Yiling Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shijiazhuang Yiling Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shijiazhuang Yiling Pharmaceutical Co Ltd.

Receive notifications about Shijiazhuang Yiling Pharmaceutical Co Ltd in your mailbox!